A 3-week-old male infant presents with seizures and tetany. Serum calcium is 6.2 mg/dL (normal 8.5–10.5). On examination, he has a long face, low-set ears, micrognathia, and a submucous cleft palate. Echocardiography reveals tetralogy of Fallot. The karyotype shows a heterozygous microdeletion on chromosome 22q11.2. The clinical diagnosis marked **D** in the diagram is most consistent with which of the following management priorities?

Explanation

## Why Option 1 is correct The clinical presentation—neonatal seizures, hypocalcemia, tetany, characteristic facies (long face, low-set ears, micrognathia), submucous cleft palate, and tetralogy of Fallot—is pathognomonic for DiGeorge/Velocardiofacial syndrome (CATCH-22), marked as **D** in the diagram. The 22q11.2 microdeletion results in thymic hypoplasia (T-cell immunodeficiency), parathyroid hypoplasia (hypoparathyroidism causing neonatal hypocalcemia), and multiple congenital heart defects. The immediate management priorities are: (1) **calcium and vitamin D supplementation** to correct life-threatening hypocalcemia and prevent seizures; (2) **T-cell count and function assessment** to quantify immunodeficiency severity and guide vaccine strategy; (3) **cardiac surgery planning** for tetralogy of Fallot repair; and (4) **strict avoidance of live vaccines** until T-cell function is confirmed adequate (Harrison 21e Ch 471). This multidisciplinary approach addresses the three cardinal neonatal emergencies: hypocalcemia, cardiac defect, and immune deficiency. ## Why each distractor is wrong - **Option 2**: While prophylactic antibiotics may be used in severe immunodeficiency, diuretics are not a priority in the acute neonatal phase. The hypocalcemia-driven seizures take precedence over heart failure management, and the sequence of interventions is incorrect. - **Option 3**: Thymic transplantation is reserved for severe SCID-like presentations with profound T-cell deficiency; it is not first-line therapy. Most 22q11 deletions have partial thymic function. IVIG is considered in severe cases, but cardiac surgery is not delayed for immune reconstitution—both proceed in parallel. - **Option 4**: Cleft palate repair timing is typically 3–6 months (not urgent in the neonatal period). Growth hormone therapy is indicated only if growth hormone deficiency is documented. Psychiatric screening for schizophrenia is a long-term surveillance issue (risk ~25% in adulthood), not an acute neonatal priority. **High-Yield:** DiGeorge/VCFS (CATCH-22) — most common microdeletion syndrome; neonatal hypocalcemia + cardiac defect + T-cell deficiency = multidisciplinary emergency management (calcium, immune workup, cardiac surgery, avoid live vaccines). [cite:Harrison 21e Ch 471; SME anchor on 22q11.2 deletion syndrome management priorities]